The Effectiveness of Rapamycin Combined with Eltrombopag in Murine Models of Immune-Mediated Bone Marrow Failure
Severe aplastic anemia (SAA) is a rare disease characterized by severe pancytopenia and bone marrow failure. Most patients with AA respond to immunosuppressive therapy (IST), usually as antithymocyte globulin (ATG) and cyclosporine (CsA), but some relapse on CsA withdrawal or require long-term admin...
Saved in:
Main Authors: | Shaoxue Ding, Xiaowei Liang, Tian Zhang, Rong Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2020/1798795 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Eltrombopag in Good’s Syndrome
by: Håvard Anton Kristiansen, et al.
Published: (2014-01-01) -
Genetic Associations in Acquired Immune-Mediated Bone Marrow Failure Syndromes: Insights in Aplastic Anemia and Chronic Idiopathic Neutropenia
by: Irene Mavroudi, et al.
Published: (2012-01-01) -
INTERNALIZATION OF EXOGENOUS DNA INTO INTERIOR COMPARTMENTS OF MURINE BONE MARROW CELLS
by: E. V. Dolgova, et al.
Published: (2014-12-01) -
Simultaneous Manifestation of Chronic Myelomonocytic Leukemia and Multiple Myeloma during Treatment by Prednisolone and Eltrombopag for Immune-Mediated Thrombocytopenic Purpura
by: Masao Hagihara, et al.
Published: (2016-01-01) -
Aplastic Anemia Treated with Eltrombopag during Pregnancy
by: Yuri Suminaga, et al.
Published: (2022-01-01)